Pfizer asked the FDA to authorize its Covid-19 booster dose for children 5 to 11 years old. The agency is expected to take a couple of weeks to conduct its review, a person familiar with the matter said. on.wsj.com
@politico.com4 years ago
FDA targets early September for approving Pfizer's Covid-19 vaccine
@snopes.com3 years ago
Merck Asks US FDA to Authorize Promising Anti-COVID Pill
@realclearpolitics.com4 years ago
Biden Shows Americans What Misinformation Looks Like
@politico.com3 years ago
Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11
@rt.com3 years ago
Pfizer sends Covid vaccine data for kids aged 5-11 to FDA as Fauci hopes to start child vaccinations by end of October
